Tazemetostat combination study in follicular lymphoma.
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2018
At a glance
- Drugs Tazemetostat (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 20 Mar 2018 New trial record
- 13 Mar 2018 According to the Epizyme media release, company plans to initiate this trial in the second half of 2018.